High-Voltage Pulsed Radiofrequency of the Lumbar Dorsal Root Ganglion for the Treatment of Chronic Lumbar Radicular and Neuropathic Pain; A Prospective, Doble-blinded and Randomized Controlled Trial

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The management of chronic lumbar radicular and neuropathic pain is complex and the treatment success rates are low. Pulsed radiofrequency (PRF) has been described in these cases. In order to determine whether high-voltage PRF show better results than PRF a prospective, doble-blinded and randomized study is conducted in patients with chronic lumbar radicular and neuropathic pain.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Patients over 18 years of age.

• Unilateral pain radiating to the lower extremity (with or without lumbar pain), which clinically corresponds to the path of the corresponding dermatomes.

• Correlation between clinical symptoms and lesion observed by magnetic resonance imaging (MRI).

• Radicular syndrome of three months or more of evolution.

• Normal or pathological electromyogram (EMG).

• Pain with neuropathic characteristics confirmed by the DN4 neuropathic pain questionnaire.

• Patients with a previous positive block diagnosis.

• Patients who have signed the informed consent document.

Locations
Other Locations
Spain
Consorci Sanitari de Terrassa
RECRUITING
Terrassa
Contact Information
Primary
Maria Martinez
mariamartinezgarcia@gmail.com
+34650528215
Backup
Maria Martinez
mariamartinezgarcia@gmail.com
650528215
Time Frame
Start Date: 2023-02-20
Estimated Completion Date: 2027-12
Participants
Target number of participants: 98
Treatments
Active_comparator: GROUP I
RFP on the affected level or levels will be carried out during three cycles of 120 s, limited to a temperature of 42° and a voltage of 45V
Experimental: GROUP II
RFP on the affected level or levels will be carried out during three cycles of 120 s, limited to a temperature of 42° and a voltage of 65V
Related Therapeutic Areas
Sponsors
Leads: Consorci Sanitari de Terrassa

This content was sourced from clinicaltrials.gov